The most practice changing trial from #ASCO25 is now live on @NEJM .If this was a drug, this would be approved today. Globally relevant and low-cost intervention that is not only delaying relapse but actually improving survival. Perfect case example of a #cancergroundshot trial.

Proud to be part of this group of cancer health services researchers who are supporting a Young Investigator Award with the @ConquerCancerFd @ASCO. Now, more than ever, we must support rigorous research. #asco2025 @WinshipAtEmory

Join @ASCO Communities of practice Health Policy Community of Practice at #ASCO25 Saturday, May 31, from 4:00 to 6:00 PM in Room S103 In a time of fluid policy change become engaged through this community. @JasmineKambojMD

So grateful for ⁦@FDAOncology⁩ ⁦@realrickpazdur⁩ for his tireless efforts to streamline regulatory processes, fostering collaboratio and innovation and getting safe and effective therapies to patients. #ASCO25 ⁦@ASCO⁩ ⁦@TheUSONetwork⁩ ⁦@jrgralow⁩

Ready for #ASCO25? Here are the plenary highlights👇 1️⃣ #ATOMIC Ph. III (Alliance A021502) in early‐stage III dMMR colon CA, where adj mFOLFOX6 goes head-to-head with the same chemo + atezo. Prim endpoint is DFS, sec are OS + AEs. So far, no interim data—all eyes on this one!

Excited to start #ASCO25 with ⁦@EMittendorfMD⁩ and Dr Sandy Swain! Come and see our talk on AI, clinical decision support, what ASCO is doing, and tools for the practice today 1pm in S100 and Saturday 4-6pm in S501. ⁦@dougfloramd⁩ ⁦@ASCO⁩ ⁦@TheUSONetwork⁩

🚨 BREAKING | Press Release today DESTINY-Breast11 🧪 Neoadjuvant Enhertu ➕ THP showed ⭐ statistically significant & clinically meaningful improvement in pCR vs ddAC➕THP In high-risk ⚠️, locally advanced HER2+ 🧬 early breast cancer Early EFS trend 📈 also favored Enhertu!

Spectacular keynote by @DavidFajgenbaum of @upenn - he is the author of “@chasingmycure” and is working in the space of repurposing the existing drugs for challenging disease scenarios. @oncologyCOA #COA2025 @dapattmd @HemOncFellows @HemOncWomenDocs @IMG_Oncologists

The ENERGY at the ⁦@oncologyCOA⁩ 2025 conference was infectious! Thank you to my ⁦@TexasOncology⁩ family for coming to support me and share knowledge. ⁦@TheUSONetwork⁩ ⁦@ASCO⁩ ⁦@ACCCBuzz⁩

Excited to be ⁦@oncologyCOA⁩ annual conference with amazing leaders in community cancer care ⁦@BarbaraMcAneny⁩

Register for the ⁦@oncologyCOA⁩ conference April 29-30 2025 in Orlando. This is the best way to collaborate with others in community oncology. I hope to see you there!

Did I seriously see a not very important regional health care system drop $8m on a Superbowl ad? And they say they're broke?

hi

Great to be ⁦⁦@avbcancercare⁩ with thought leaders in cancer care to come to better solutions together ⁦@TexasOncology⁩ ⁦@TheUSONetwork⁩ ⁦@FLCancerFound⁩ ⁦@weareOnCare⁩

Inspired to be with my teenage son watching Starship make necessary progress to plan for a trip to Mars. The orbital stage rocket AND CATCH was incredible! ⁦@SpaceX⁩ ⁦@SpaceXStarship⁩ ⁦@StarshipGazer⁩

While we have a heavy heart today remembering the events of Oct 7 and all of the destruction that has happened since, I appreciate the support and engagement from our community leaders ⁦@texasgov⁩ ⁦@GovAbbott⁩ ⁦⁦@AgudasAchimATX⁩ 🙏🏻 for ☮️

So inspired ⁦⁦@ASCO⁩ #ASCOQLTY24 where ⁦@EthanBasch1⁩ enlightened us all to his vision of quality improvement in accepting the well deserved Joe Simone Quality Award. 🥇

Fantastic discussion of patient support ⁦@ASCO⁩ #ascoqlty24

The 2024 @df_hcc Breast Cancer Program Research Retreat - @DFCI_BreastOnc https://t.co/VD2xFxMBKR @dapattmd @jhalamka @zakkohane #Cancer #BCSM #Health #Medicine #MedTwitter #OncoDaily #Oncology

Medicare Drug Price Negotiation Program Will Result in Financial Burdens for Community Oncology Practices @dapattmd @oncologyCOA @TexasOncology @TheUSONetwork @DellMedSchool https://t.co/ody34Qp9lm